Options Brief: GTx, Inc.

Shares of GTx, Inc. GTXI are lower on the session by 0.50%, trading at $6.03. Overall call volume is now running at 5.15x the daily average, with 89% of all calls traded being purchases on the offer. 1,376 contracts have traded on the session so far. GTx, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that targets hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical conditions.